Taysha Gene Therapies shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $44M | 13M | 3.27 |
| 2025-03-31 | $499k | 359k | 1.39 |
| 2024-12-31 | $1.7M | 967k | 1.73 |
| 2024-09-30 | $2.4M | 1.2M | 2.01 |
| 2024-06-30 | $2.3M | 1.0M | 2.24 |
| 2024-03-31 | $3.0M | 1.1M | 2.87 |
| 2023-12-31 | $148k | 84k | 1.77 |
| 2022-12-31 | $27k | 12k | 2.26 |
| 2022-06-30 | $257k | 69k | 3.71 |
| 2022-03-31 | $580k | 89k | 6.51 |
| 2021-12-31 | $618k | 53k | 11.64 |
| 2021-09-30 | $225k | 12k | 18.60 |
| 2020-12-31 | $392k | 15k | 26.55 |
| 2020-09-30 | $1.8M | 79k | 22.40 |